🇺🇸 Adefovir dipivoxil (adefovir) in United States

26 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 21 April 2025 – 21 April 2026
• Total reports: 26

Most-reported reactions

1. Alanine Aminotransferase Increased — 3 reports (11.54%)
2. Ascites — 3 reports (11.54%)
3. Aspartate Aminotransferase Increased — 3 reports (11.54%)
4. Atelectasis — 3 reports (11.54%)
5. Hepatitis B — 3 reports (11.54%)
6. Hypotension — 3 reports (11.54%)
7. Anorexia — 2 reports (7.69%)
8. Bilirubin Conjugated Increased — 2 reports (7.69%)
9. Blood Creatinine Increased — 2 reports (7.69%)
10. Blood Lactate Dehydrogenase Increased — 2 reports (7.69%)

Source database →

Frequently asked questions

Is Adefovir dipivoxil (adefovir) approved in United States?

Adefovir dipivoxil (adefovir) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Adefovir dipivoxil (adefovir) in United States?

Merck Sharp & Dohme LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.